secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2024-06-28T23:59:59+00:00
Accession:  0001730463-24-000076
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Autolus Therapeutics shareholders approve all nine resolutions at 2024 AGM
--------------------------------------------------------------------------

- Adoption of 2023 annual accounts passed with 190.78M votes for, 35.8K against.
- Directors' remuneration report approved: 167.10M for, 23.69M against.
- Ernst & Young LLP reappointed as auditors for the coming year.
- All four director re-elections passed: Bain (99.52%), Butitta (98.36%), Itin (99.83%), Young (99.12%).
- Board authorized to allot shares up to $8,400 nominal value (Resolution 8) and disapply pre-emption rights (Resolution 9).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046324000076/0001730463-24-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046324000076/autl-20240628.htm
  HTML page:      https://secwatch.observer/filing/0001730463-24-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer